1,041 material Form 8-K filings that 824 companies we cover made with the SEC in November 2025, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
Avantor named Mary Blenn Executive Vice President and Chief Operating Officer, a newly created role, effective immediately. She will lead manufacturing and supply chain operations and report to President and CEO Emmanuel Ligner. The filing also sets out her pay package, including a $500,000 base salary and a $5,000,000 target equity grant.
Mary Blenn appointed EVP and Chief Operating Officer, effective immediately; role is newly created
Base salary of $500,000 with a target annual bonus of 75% of base salary
Initial equity grant with target grant date fair value of $5,000,000, with $400,000 awarded at her start date and the remainder in February 2026
The filing also amends the education description of CEO Emmanuel Ligner and adds committee appointments for director Gregory Lucier effective November 6, 2025
Albertsons issued $700 million of 5.500% senior notes due 2031 and $800 million of 5.750% senior notes due 2034. Proceeds, plus cash on hand, will redeem all $750 million of its 3.250% notes maturing March 15, 2026, and repay part of its asset-based revolving credit borrowings. The filing shows a debt refinancing that extends maturities; it does not report earnings or guidance.
Issued $700 million of 5.500% senior notes due March 31, 2031 and $800 million of 5.750% senior notes due March 31, 2034
Proceeds and cash on hand will redeem all $750 million of 3.250% notes due March 15, 2026, and repay part of the revolving credit borrowings
Interest is payable semi-annually on May 15 and November 15, starting May 15, 2026; the notes are unsecured and guaranteed by domestic subsidiaries
Greif reported a two-month fourth quarter ended September 30, 2025, with a net loss from continuing operations of $43.3 million, compared with net income of $34.0 million a year earlier, while Adjusted EBITDA rose 7.4% to $98.9 million. The company also gave low-end fiscal 2026 guidance of $630 million Adjusted EBITDA and $315 million Adjusted free cash flow, raised its cost optimization commitment to $120 million, and plans a share repurchase of about $150 million.
Q4 net loss from continuing operations of $43.3 million, or $(0.73) per diluted Class A share, versus $34.0 million, or $0.58, a year earlier
Adjusted net income fell 98.2% to $0.6 million, or $0.01 per diluted Class A share
Eleven-month fiscal 2025 net income fell 93.2% to $15.1 million, or $0.28 per diluted Class A share; Adjusted EBITDA rose 3.1% to $511.3 million
Containerboard business sold to Packaging Corporation of America for $1.8 billion; timberlands sale for about $462.0 million completed October 1, 2025
Tidewater reported third-quarter 2025 revenue of $341.1 million, up 0.2% from a year earlier, but swung to a net loss of $0.8 million, or $0.02 per diluted share, from net income of $46.4 million a year earlier. The loss reflects a $27.1 million loss on early debt extinguishment tied to the July 2025 refinancing. The company also narrowed its 2025 revenue guidance and initiated 2026 revenue guidance of $1.32 billion to $1.37 billion.
Q3 2025 revenue of $341.1 million versus $340.4 million in Q3 2024; net loss of $0.8 million versus net income of $46.4 million
Loss on early extinguishment of debt of $27.1 million associated with the July 2025 refinancing
2025 revenue guidance narrowed to $1.33 billion to $1.35 billion; 2025 gross margin guidance of 49% to 50%
2026 guidance initiated at $1.32 billion to $1.37 billion in revenue and 48% to 50% gross margin; $500 million share repurchase authorization outstanding
Northern Oil and Gas entered a Fourth Amended and Restated Credit Agreement with Wells Fargo as administrative agent, replacing its prior revolving credit facility from June 7, 2022. The facility has an initial elected commitment of $1.6 billion, a borrowing base of $1.8 billion, and a November 5, 2030 maturity, and is secured by mortgages on at least 85% of the value of proven reserves. The filing describes this as a refinancing of existing borrowing capacity rather than a change in results, but the updated covenants and collateral terms apply to shareholders' company going forward.
Initial elected commitment of $1.6 billion; initial borrowing base of $1.8 billion, redetermined semiannually around April 1 and October 1
Matures November 5, 2030, replacing the facility entered into June 7, 2022
Interest at base rate or SOFR plus margins of 175 to 275 basis points for SOFR loans, depending on utilization
Financial covenants include a maximum net debt to EBITDAX ratio of 3.50 to 1.00 and a minimum current ratio of 1.00 to 1.00
Sylvamo's board declared a dividend of one preferred share purchase right per common share, payable November 20, 2025, and entered into a Rights Agreement with Computershare Trust Company, N.A. The board adopted the plan after Atlas Holdings directed its two affiliated directors to resign, which terminated a 2023 cooperation agreement; the company says the plan is designed to protect long-term value for all shareowners.
Rights are triggered if a person or group acquires 15% or more of common shares, or 20% for certain passive investors; the trigger was 10% under the 2022 plan.
Atlas Holdings has economic exposure to approximately 21.5% of outstanding common stock, consisting of 16% beneficial ownership and 5.5% through derivatives, per the company.
Each right allows purchase of one one-thousandth of a Series B Preferred Share at $215.00, subject to adjustment; the rights expire November 9, 2026.
Darling Ingredients said General Counsel and Secretary John F. Sterling intends to retire on March 31, 2027. Nick Kemphaus, the current Senior Vice President and Deputy General Counsel, will take over Sterling's title and duties on January 4, 2026, when Sterling stops serving as an executive officer and moves to an advisory role. The change is a planned leadership succession in the legal function, with no financial results disclosed in the filing.
John F. Sterling intends to retire March 31, 2027, and will stay in an advisory role after January 4, 2026
Nick Kemphaus, age 47, will assume the General Counsel and Secretary title on January 4, 2026
Sterling's base salary stays unchanged until March 31, 2026, then drops to $120,000; he will not join the 2026 or 2027 incentive programs
Rocket Lab reported third-quarter 2025 revenue of $155 million, up 48% from a year earlier, and a net loss of $18.3 million, narrower than the $51.9 million loss in the same quarter of 2024. The company guided fourth-quarter revenue to $170 million to $180 million, and director Matt Ocko will leave the board effective November 30, 2025, in a resignation the company says was not due to any disagreement.
Q3 2025 total revenue was $155.1 million, up from $104.8 million in Q3 2024.
Q3 2025 net loss was $18.3 million, or $0.03 per share, versus a $51.9 million net loss in Q3 2024.
Fourth-quarter 2025 guidance: revenue of $170 million to $180 million and GAAP gross margin of 37% to 39%.
Director Matt Ocko notified the company on November 7, 2025, that he will resign from the board effective November 30, 2025.
StandardAero reported third-quarter 2025 revenue of $1,498.0 million, up 20.4% from a year earlier, and net income of $68.1 million, compared with $16.4 million in the prior-year quarter. The company raised its full-year 2025 guidance for revenue, Adjusted EBITDA and free cash flow, which signals higher expected earnings and cash generation for the year for shareholders. Adjusted EBITDA margin declined to 13.1% from 13.5%.
Q3 2025 revenue was $1,498.0 million, up $253.3 million, or 20.4%, from $1,244.6 million
Q3 2025 net income was $68.1 million, compared with $16.4 million a year earlier
Full-year 2025 revenue guidance raised to $5,970 million to $6,030 million from $5,875 million to $6,025 million
Free cash flow guidance raised to $170 million to $190 million from $155 million to $175 million
BWX Technologies issued $1.25 billion of 0% convertible senior notes due November 1, 2030, including a $150 million option the initial purchasers exercised in full. The company plans to use part of the net proceeds to repay $830.8 million under its existing credit facility and $116.1 million to fund capped call transactions, which are intended to reduce potential dilution from conversions.
Notes issued November 10, 2025: $1.25 billion total, including an additional $150 million exercised November 6, 2025
Initial conversion price of approximately $262.51 per share, a premium of about 32.5% to the $198.12 last reported sale price on November 5, 2025
Planned use of proceeds: about $830.8 million to repay the existing credit facility and about $116.1 million for capped call transactions
Company may not redeem the notes before November 6, 2028; the notes mature November 1, 2030
Occidental reported third-quarter 2025 net income attributable to common stockholders of $661 million, or $0.65 per diluted share, and adjusted income of $649 million, or $0.64 per share. Results improved sharply from the second quarter but declined from the third quarter of 2024, and the company repaid $1.3 billion of debt, reducing principal debt to $20.8 billion.
Q3 2025 reported EPS $0.65 vs $0.26 in Q2 2025 and $0.98 in Q3 2024; adjusted EPS $0.64 vs $0.39 in Q2 2025 and $1.00 in Q3 2024
Total company production of 1,465 Mboed exceeded the high end of guidance
Operating cash flow of $2.8 billion; $1.3 billion of debt repaid in the quarter
Life360 reported unaudited third-quarter 2025 revenue of $124.5 million, up 34% year over year, and net income of $9.8 million, up 27%. It raised full-year 2025 revenue guidance to $474 million to $485 million and Adjusted EBITDA guidance to $84 million to $88 million. It also agreed to acquire Nativo, Inc. in a transaction valued at approximately $120 million in cash and common stock, with completion expected in January 2026.
Q3 2025 Adjusted EBITDA was $24.5 million, up from $9.0 million in Q3 2024.
Q3 2025 net income was $9.8 million, compared with $7.7 million in Q3 2024.
FY2025 revenue guidance raised to $474 million to $485 million from $462 million to $482 million; Adjusted EBITDA guidance raised to $84 million to $88 million from $72 million to $82 million.
Hardware gross profit and margin were affected by tariff-related costs, and Q3 hardware revenue fell 4% year over year to $11.3 million.
CoreWeave reported third-quarter 2025 results for the period ended September 30, 2025, with revenue of $1.36 billion, up from $583.9 million a year earlier. Net loss narrowed to $110.1 million, or $0.22 per share, from $359.8 million, or $1.82 per share, in the prior-year quarter. Operating income fell to $51.9 million from $117.1 million, and the company did not provide guidance in the release, saying it would give forward-looking guidance on its earnings call.
Revenue was $1.36 billion, compared with $583.9 million in the third quarter of 2024.
Net loss was $110.1 million, or $0.22 per share, compared with a net loss of $359.8 million, or $1.82 per share, a year earlier.
Operating income was $51.9 million, compared with $117.1 million, and adjusted EBITDA was $838.1 million.
Revenue backlog was $55.6 billion as of September 30, 2025; the release gives no forward guidance, which is to be provided on the earnings call.
First Financial Bancorp completed the sale of $300 million of 6.375% fixed-to-floating rate subordinated notes due 2035 on November 10, 2025. Net proceeds are approximately $296.3 million before offering expenses, which the company plans to use for general corporate purposes, including a potential redemption of its 5.25% subordinated notes due 2030. The filing describes new debt that adds to the company's obligations, but it does not report a change in earnings or guidance.
Principal of $300 million; fixed rate of 6.375% until December 1, 2030, then a floating rate of Three-Month Term SOFR plus 300 basis points until maturity on December 1, 2035
Net proceeds of approximately $296.3 million after a 1.25% underwriting discount, before offering expenses
Proceeds may fund a potential redemption of the company's 5.25% subordinated notes due 2030
Notes rank junior to all senior indebtedness and are not guaranteed by subsidiaries; underwriters were Keefe, Bruyette & Woods and Janney Montgomery Scott
On November 10, 2025, BMS Ireland Capital Funding Designated Activity Company, a wholly owned subsidiary, completed a public offering of five series of euro-denominated senior unsecured notes guaranteed by Bristol-Myers Squibb. The company plans to use the proceeds, together with approximately $3.0 billion of cash on hand, mainly to fund a tender offer for various series of its outstanding notes, with any remaining proceeds for general corporate purposes. For shareholders, the filing shows a debt refinancing that reshapes the maturity profile rather than a change in operations.
Five series totaling €5.0 billion: €750 million due 2030, €1.15 billion due 2033, €1.15 billion due 2038, €750 million due 2045, and €1.2 billion due 2055
Coupons range from 2.973% (2030 Notes) to 4.581% (2055 Notes), with interest payable annually beginning November 10, 2026
Proceeds, plus about $3.0 billion of cash on hand, are earmarked for the tender offer for outstanding notes, fees and expenses, and general corporate purposes
Offering made under a prospectus supplement dated November 5, 2025 and an underwriting agreement dated November 5, 2025
Paramount Skydance reported third-quarter 2025 results, with pro forma revenue flat at $6.7 billion versus Q3 2024. The company reported net losses of $244 million before the August 6 deal close and $13 million after it, and issued a 2026 outlook of $30 billion in total revenue and $3.5 billion in adjusted OIBDA. For shareholders, the filing shows flat sales and losses in the reported periods, alongside higher adjusted OIBDA and a raised cost-savings target.
Pro forma Q3 2025 total revenue was $6.7 billion, flat versus $6.7 billion in Q3 2024.
Adjusted OIBDA was $297 million pre-close and $655 million post-close; the company expects Q4 2025 revenue of $8.1 billion to $8.3 billion and 2026 revenue of $30 billion.
Run-rate efficiency target raised to at least $3 billion from $2 billion, and about 1,000 employees were cut at the end of October.
Kemper's Human Resources and Compensation Committee approved retention awards on November 4, 2025 for three named executive officers, including the CFO, Chief Investment Officer and head of Kemper Auto. The awards are restricted stock units vesting in two equal halves over one and two years, and they follow recently announced leadership changes at the company. Shareholders should note the awards are meant to keep key executives in place during this transition.
Retention awards approved November 4, 2025 for Bradley T. Camden ($775,000), John M. Boschelli ($675,000) and Matthew A. Hunton ($775,000)
Camden is Executive Vice President and Chief Financial Officer; Boschelli is Executive Vice President and Chief Investment Officer; Hunton is Executive Vice President and President, Kemper Auto
Awards are restricted stock units; 50% vest on the first anniversary and 50% on the second anniversary of the grant date, subject to continued service
Grant date expected to be the first trading day in December 2025; the Interim CEO's separate award was disclosed in a November 7, 2025 Form 8-K/A
AMETEK announced that Thomas M. Montgomery, its Senior Vice President, Comptroller and Principal Accounting Officer, will retire effective January 1, 2026, and remain as a Senior Advisor through 2026. Robert J. Amodei, currently Vice President, Assistant Controller, will succeed him as Senior Vice President, Controller and Principal Accounting Officer on the same date. The change affects the company's top accounting role but the filing reports no financial results.
Thomas M. Montgomery retires effective January 1, 2026, after 42 years with the company and stays on as Senior Advisor through 2026
Robert J. Amodei, 58, has been with AMETEK for 36 years and becomes Senior Vice President, Controller and Principal Accounting Officer effective January 1, 2026
Scott M. DelOrefice named Vice President, Group Controller, Electromechanical Group effective January 1, 2026
Mr. Amodei will be an executive officer of the company in his new role
Ball Corporation's board appointed Ronald J. Lewis as chief executive officer and a director, effective immediately, replacing Daniel W. Fisher, who also left the chairman role. Stuart A. Taylor II became chairman and the lead independent director position was eliminated, and Daniel Rabbitt was appointed chief financial officer. The company reaffirmed its full-year comparable diluted earnings per share growth outlook of 12-15%, so the leadership change came without a stated change to that guidance.
Ronald J. Lewis, 59, named CEO effective immediately, with a $1,000,000 initial base salary and a 150% target annual cash incentive
Stuart A. Taylor II named Chairman of the Board; the Lead Independent Director position was eliminated
Daniel Rabbitt, 57, appointed CFO effective immediately after serving as interim CFO since May 2025, with a $700,000 initial base salary
Company reaffirmed its full-year comparable diluted EPS growth outlook of 12-15%
Chief Executive John Geller resigned at the board's request, effective November 10, 2025, and also left the board. Director Matthew Avril became interim President and CEO, and the board has started a search for a permanent CEO. The company reaffirmed its 2025 guidance and postponed its December 17 Investor Day, while saying it intends to buy back shares under its remaining $347 million program during the quarter.
John Geller resigned as President, CEO and director at the board's request, effective November 10, 2025
Geller's separation agreement provides severance of $5 million and a prorated 2025 target bonus of $1,286,301
Matthew Avril, a director since 2025, will be interim CEO at an annual base salary of $1 million
Company reaffirmed 2025 guidance issued November 5, 2025, and postponed the December 17 Investor Day
ANI Pharmaceuticals filed an updated investor presentation that restates its third-quarter 2025 results, with total revenue of $228 million, up 54% year over year, and adjusted diluted EPS of $2.04, up 52%. The presentation says the company raised its full-year 2025 guidance for net revenue, adjusted EBITDA and adjusted diluted EPS, with the guidance issued on November 7, 2025. For shareholders, the higher outlook is a positive signal, although ILUVIEN revenue was pressured and the profit figures are non-GAAP measures.
Q3 2025 total revenue was $228 million, up 54% year over year; adjusted non-GAAP EBITDA was $60 million, up 70%; adjusted non-GAAP diluted EPS was $2.04, up 52%.
Full-year 2025 net revenue guidance is $854 million to $873 million, up from a previous $818 million to $843 million.
Full-year 2025 adjusted non-GAAP EBITDA guidance is $221 million to $228 million (previously $213 million to $223 million), and adjusted non-GAAP diluted EPS guidance is $7.37 to $7.64 (previously $6.98 to $7.35).
Q3 2025 ILUVIEN revenue was $17 million, which the company said was pressured by reduced access for Medicare patients and remaining YUTIQ units at physician offices.
Mastercard and its subsidiary entered an updated class settlement with court-appointed counsel for a US merchant injunctive relief class, with Visa also a party. The agreement is subject to final approval by the Eastern District Court of New York, and Mastercard says it would resolve all pending US merchant litigation seeking changes to its interchange structure and merchant acceptance rules. A 10 basis point reduction in the average systemwide effective interchange rate on US-issued consumer and commercial credit transactions would reduce Mastercard's interchange revenue on those transactions, a cost to shareholders that is weighed against the removal of ongoing litigation risk.
Both Mastercard and Visa agree to a 10 basis point reduction in the average systemwide effective interchange rate on US-issued consumer and commercial credit transactions at US merchant locations.
The interchange reduction is designed to act as a cap for five years.
The agreement is subject to final approval by the Eastern District Court of New York, expected most likely in late 2026 or early 2027.
Mastercard does not admit to any improper conduct regarding the plaintiffs' allegations.
RadNet reported third-quarter 2025 revenue of $522.9 million, up 13.4%, and Adjusted EBITDA of $84.9 million, up 15.2%. Net income attributable to RadNet stockholders was $5.4 million, or $0.07 per diluted share, compared with $3.2 million, or $0.04, a year earlier. The company raised its full-year 2025 revenue and Adjusted EBITDA guidance for the Imaging Center segment and its revenue guidance for Digital Health, which is a positive signal for shareholders.
Q3 2025 revenue was $522.9 million, up from $461.1 million; Adjusted EBITDA was $84.9 million, up 15.2%.
Q3 2025 net income attributable to RadNet was $5.4 million, or $0.07 per diluted share, versus $3.2 million, or $0.04, in Q3 2024.
Imaging Center 2025 revenue guidance was raised to $1,900 - $1,930 million and Adjusted EBITDA guidance to $276 - $284 million.
For the first nine months of 2025, the company reported a net loss of $18.1 million, or $(0.24) per share; cash was $804.7 million at September 30, 2025.
Organon reported third-quarter 2025 revenue of $1.602 billion, up 1% as reported and down 1% excluding foreign exchange, while GAAP net income fell to $160 million, or $0.61 per diluted share, from $359 million, or $1.38, a year earlier. The company lowered its full-year 2025 revenue guidance to $6.200 billion to $6.250 billion from $6.275 billion to $6.375 billion, a reduction in its outlook that matters to shareholders. Non-GAAP adjusted diluted EPS rose to $1.01 from $0.87.
Q3 2025 revenue was $1.602 billion, up 1% as reported and down 1% ex-FX; Women's Health fell 3% and Biosimilars rose 19%.
Reported gross margin was 53.5% versus 58.3% a year earlier; one-time manufacturing network optimization costs were the most significant driver.
Full-year 2025 revenue guidance was lowered to $6.200 billion to $6.250 billion; Adjusted EBITDA margin guidance was lowered to about 31.0% from 31.0% to 32.0%.
The board declared a quarterly dividend of $0.02 per share, payable December 11, 2025; Joe Morrissey is interim CEO.
Tyson Foods reported fourth-quarter fiscal 2025 sales of $13,860 million, up 2.2%, and adjusted EPS of $1.15, up 25%, while GAAP EPS fell to $0.13 from $1.00 a year earlier. The company also gave a fiscal 2026 outlook for total adjusted operating income of $2.1 billion to $2.3 billion and raised its quarterly dividend, so shareholders face a mix of higher adjusted results, a sharp GAAP profit decline and a guided adjusted operating income range that sits below fiscal 2025's $2,287 million.
Q4 sales of $13,860 million, up 2.2%; GAAP operating income of $158 million, down 70%
Q4 sales were reduced by $355 million in legal contingency accruals; GAAP EPS of $0.13 versus adjusted EPS of $1.15
Fiscal 2026 outlook: total adjusted operating income of $2.1 billion to $2.3 billion and sales up 2% to 4%, compared with fiscal 2025 adjusted operating income of $2,287 million
Quarterly dividend increased to $0.51 per Class A share, effective November 7, 2025
Roivant reported results for the quarter ended September 30, 2025. Net loss attributable to Roivant shareholders narrowed to $113.5 million from $230.2 million a year earlier, while revenue fell to $1.6 million from $4.5 million. R&D spending rose, and the company reported $4.4 billion in cash, cash equivalents, restricted cash and marketable securities.
Net loss attributable to Roivant was $113.5 million, or $0.17 per share, versus $230.2 million, or $0.31 per share, a year earlier
Revenue was $1.6 million versus $4.5 million in the prior-year quarter
R&D expenses rose to $164.6 million from $143.1 million; G&A expenses fell to $143.1 million from $202.9 million
Cash and marketable securities totaled $4.4 billion as of September 30, 2025; Investor Day is set for December 11, 2025
Maplebear (Instacart) reported third-quarter 2025 revenue of $939 million, up 10% year-over-year, and GAAP net income of $144 million, up 22%. Its board also raised the share repurchase authorization to $2.5 billion from $1 billion, and the company plans a $250 million accelerated share repurchase, which matters to shareholders as a large capital return and a sign of confidence in its cash generation.
Q3 2025 orders of 83.4 million, up 14% year-over-year; GTV of $9,170 million, up 10%
Total revenue $939 million, up 10%; GAAP gross profit $692 million, up 8%, but a lower share of GTV and revenue than in Q3 2024
GAAP net income $144 million, up 22%; adjusted EBITDA $278 million, up 22%
Q4 2025 outlook: GTV of $9,450 million to $9,600 million and adjusted EBITDA of $285 million to $295 million; $250 million accelerated share repurchase with Goldman Sachs expected to begin November 11, 2025
Starwood Property Trust reported third-quarter 2025 GAAP net income of $72.6 million and Distributable Earnings of $148.6 million, or $0.40 per diluted share. The company invested $4.6 billion in the quarter and ended it with record liquidity of $2.2 billion, including the Fundamental net lease portfolio acquisition. The filing does not include prior-period comparisons, so the direction of change versus last year cannot be determined from it.
GAAP net income of $72.6 million, or $0.19 per share, for the quarter ended September 30, 2025, after a $28.4 million credit loss provision and $26.0 million of depreciation
Distributable Earnings of $148.6 million, or $0.40 per diluted share
Invested $4.6 billion in the quarter, including $2.2 billion of triple net lease investments and a record $0.8 billion in infrastructure lending
Record liquidity of $2.2 billion; paid a quarterly dividend of $0.48 per share
BankUnited appointed James G. Mackey as chief financial officer effective November 10, 2025, succeeding Leslie N. Lunak, who had held the CFO role since 2013. Lunak remains with the company as executive advisor through January 2026. The change was previously announced in July 2025, so the filing confirms a planned succession rather than a new development.
Mackey was hired July 23, 2025, and served as senior executive vice president of finance from August 15, 2025, to November 10, 2025.
Lunak stepped down as CFO on November 10, 2025, and will continue as executive advisor through January 2026.
The company's press release announcing the appointment is furnished as Exhibit 99.1; CEO Rajinder Singh signed the filing.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.